| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ceftazidime measurement |
Component |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime poisoning |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Accidental ceftazidime poisoning |
Causative agent (attribute) |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Intentional ceftazidime poisoning |
Causative agent (attribute) |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| intoxication par la ceftazidime d'intention indéterminée |
Causative agent (attribute) |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime adverse reaction |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime overdose |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Accidental ceftazidime overdose (disorder) |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Intentional ceftazidime overdose |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| surdose de ceftazidime d'intention indéterminée |
Causative agent (attribute) |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| ceftazidime 3 g, flacon de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| ceftazidime 250 mg, flacon de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 2g powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Product containing ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime sodium 2g/50 mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 1g/25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 2g/50mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 6g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 1g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 2g/100mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 500mg/15mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 1g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 10g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 100g/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 6g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 1g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 2g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate 2g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 2000mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 10g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 20mg infusion solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate 6g infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate 100mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 500mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 10g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 1g/100mL powder for injection 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 500mg powder for injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 6g/100mL powder for injection 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 2g/50mL powder for injection 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 2g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 1g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime 6g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 1g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 1g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate 2g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 2g/50 mL intravenous solution 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime (arginine formula) 2g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| ceftazidime 500 mg, pour injection (poudre pour reconstitution) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| ceftazidime 1 g, pour injection (poudre pour reconstitution) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| ceftazidime 2 g, pour injection (poudre pour reconstitution) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Accidental ceftazidime poisoning |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Intentional ceftazidime poisoning |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ceftazidime (finding) |
Causative agent (attribute) |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Allergy to ceftazidime (finding) |
Causative agent (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Avibactam and ceftazidime |
Is a |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate (substance) |
Is a |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime desensitisation therapy |
Using substance (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
2 |
| Avibactam and ceftazidime |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime pentahydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime sodium 2g/50 mL conventional release solution for infusion 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| ceftazidime 3 g, flacon de poudre pour solution injectable |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| ceftazidime 1 g, pour injection (poudre pour reconstitution) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| ceftazidime 250 mg, flacon de poudre pour solution injectable |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| ceftazidime 500 mg, pour injection (poudre pour reconstitution) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| ceftazidime 2 g, pour injection (poudre pour reconstitution) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Product containing only avibactam and ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Product containing only avibactam and ceftazidime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Product containing avibactam and ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Avibactam- and ceftazidime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
| Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 1 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 3 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 3 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 250 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Avibactam (as avibactam sodium) 500 mg and ceftazidime 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Avibactam (as avibactam sodium) 500 mg and ceftazidime 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 1 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 1 g powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 2 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime 2 g powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
| Ceftazidime therapy (procedure) |
Direct substance |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]